Cardinal Health (CAH) Stock Forecast, Price & News

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 8 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings or view top-rated stocks.

11 brokerages have issued 1 year price targets for Cardinal Health's stock. Their CAH share price forecasts range from $80.00 to $108.00. On average, they expect the company's share price to reach $94.69 in the next twelve months. This suggests a possible upside of 9.1% from the stock's current price.
View analysts price targets for CAH or view top-rated stocks among Wall Street analysts.

Cardinal Health's stock was trading at $76.87 at the beginning of the year. Since then, CAH stock has increased by 12.9% and is now trading at $86.79.
View the best growth stocks for 2023 here.

Cardinal Health saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 8,140,000 shares, a decline of 23.8% from the August 31st total of 10,680,000 shares. Based on an average daily trading volume, of 2,150,000 shares, the days-to-cover ratio is currently 3.8 days. Currently, 3.3% of the company's stock are short sold.
View Cardinal Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Friday, November 3rd 2023.
View our CAH earnings forecast.

Cardinal Health will be holding an earnings conference call on Friday, November 3rd at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Cardinal Health, Inc. (NYSE:CAH) announced its quarterly earnings data on Tuesday, August, 15th. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.06. The company earned $53.45 billion during the quarter, compared to analysts' expectations of $52.72 billion. Cardinal Health had a negative trailing twelve-month return on equity of 67.01% and a net margin of 0.13%. The firm's revenue for the quarter was up 13.5% on a year-over-year basis. During the same quarter last year, the firm earned $1.05 EPS.
Read the conference call transcript.

Cardinal Health announced a quarterly dividend on Wednesday, August 9th. Shareholders of record on Tuesday, October 3rd will be paid a dividend of $0.5006 per share on Sunday, October 15th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.31%. The ex-dividend date of this dividend is Monday, October 2nd.
Read our dividend analysis for CAH.

ETFs with the largest weight of Cardinal Health (NYSE:CAH) stock in their portfolio include USCF Dividend Income Fund (UDI), First Trust Nasdaq Pharmaceuticals ETF (FTXH), WBI BullBear Yield 3000 ETF (WBIG), BlackRock Large Cap Value ETF (BLCV), LeaderShares AlphaFactor Tactical Focused ETF (LSAT), SEI Enhanced U.S. Large Cap Value Factor ETF (SEIV), First Trust Dorsey Wright Momentum & Value ETF (DVLU) and Invesco Bloomberg MVP Multi-factor ETF (PWC).

Cardinal Health (NYSE:CAH) pays an annual dividend of $2.00 per share and currently has a dividend yield of 2.27%. The company has been increasing its dividend for 38 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 202.02%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CAH will have a dividend payout ratio of 26.46% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

Cardinal Health updated its FY 2024 earnings guidance on Tuesday, August, 15th. The company provided earnings per share (EPS) guidance of $6.50-$6.75 for the period, compared to the consensus estimate of $6.59. The company issued revenue guidance of -.

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CAH stock can currently be purchased for approximately $86.79.

Cardinal Health (NYSE:CAH) has a market capitalization of $21.76 billion and generates $205.01 billion in revenue each year. The company earns $261 million in net income (profit) each year or $0.99 on an earnings per share basis.

The company employs 48,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The official website for the company is www.cardinalhealth.com. The company can be reached via phone at (614) 757-5000, via email at investor.relations@cardinalhealth.com, or via fax at 614-757-6000.